BD PharmingenTM APC Mouse Anti-Human CCR9 (CD199)

Description

Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Multicolor flow cytometric analysis of CCR9 CD199 expression on human peripheral blood mononuclear cells. Human PBMCs were stained with BD Horizon BUV395 Mouse Anti-Human CD4 antibody Cat. No. 564724 and APC Mouse IgG1, kappa Isotype Control Cat. No. 554681; Left Plot or APC Mouse Anti-Human CCR9 CD199 antibody Cat. No. 567976/567977; Right Plot . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. Bivariate pseudocolor density plots showing the correlated expression of CCR9 CD199 or Ig Isotype control staining versus CD4 were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis was performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software.